Market Research Logo

US Market Overview for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - MedView

US Market Overview for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - MedView

Stereotaxy has become the standard of care in neurosurgery therefore the market for stereotactic systems is saturated, limiting growth in market value. Innovative technology and updated features and software will be required to encourage growth. New competitors have entered the neuromodulation market which will drive competitive pressure in technological advancement and pricing. This will have the greatest impact on the spinal cord stimulator and deep brain stimulator markets. One of the major market drivers for neurological devices is the patient and physicians demand for minimally invasive procedures. This has been driving the growth in interventional neuroradiology and neuroendoscopy. This has led to procedural growth in endovascular embolization treatments and a decline in aneurysm clipping procedures treatments. Access devices are becoming increasingly technologically advanced and various embolization devices have been released in recent years. One of the major emerging trends is the growth of mechanical thrombectomy devices for ischemic stroke. These devices extend the window for treatment of patients compared to medical therapy alone and can provide dramatically improved clinical outcomes.

The full report suite on the U.S. market for neurological devices includes cerebrospinal fluid shunts, cerebrospinal fluid external drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, catheters, guidewires, balloon occlusion devices, neurovascular stents and flow diversion stents, spinal cord stimulators, vagus nerve stimulators, sacral nerve stimulators, deep brain stimulators, gastric electric stimulators, neuroendoscopes, stereotactic frames, stereotactic frameless systems, ultrasonic aspirators, aneurysm clips, neurosurgical microscopes, intrathecal pumps and mechanical thrombectomy devices.


EXECUTIVE SUMMARY
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics and Neurosurgery
2.2.3 Tumor and Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder
2.2.7.2 Cerebral Edema
2.2.8 Indication for Neuromodulation
2.2.9 Traumatic brain injury
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 Cerebrospinal Fluid Management
3.1.2 Interventional Neuroradiology
3.1.3 Neuromodulation
3.1.4 Introduction to Neurosurgery
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY SEGMENT
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.1.1 Cerebrospinal Fluid Management
3.4.1.2 Interventional Neuroradiology
3.4.1.3 Neuromodulation
3.4.1.4 Neurosurgery
3.4.2 Market Limiters
3.4.2.1 Cerebrospinal Fluid Management
3.4.2.2 Interventional Neuroradiology
3.4.2.3 Neuromodulation
3.4.2.4 Neurosurgery
3.5 COMPETITIVE MARKET SHARE ANALYSIS
3.6 COMPANY PROFILES
3.6.1 B. Braun
3.6.2 Boston Scientific
3.6.3 BrainLab
3.6.4 Carl Zeiss
3.6.5 Codman & Shurtleff
3.6.6 Integra LifeScience
3.6.7 Leica Microsystems
3.6.8 LivaNova, PLC
3.6.9 Medtronic
3.6.10 MicroVention Terumo
3.6.11 Mizuho Co., Ltd.
3.6.12 St. Jude Medical
3.6.13 Stryker
3.6 MERGERS AND ACQUISITIONS
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023
Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023
Chart 3 1: Neurological Device Market by Segment, U.S., 2013 – 2023
Chart 3 2: Neurological Device Market Breakdown, U.S., 2016
Chart 3 3: Neurological Device Market Breakdown, U.S., 2023
Chart 3 4: Growth Rates by Segment, Neurological Device Market, U.S., 2013 – 2023
Chart 3 5: Leading Competitors, Neurological Device Market, U.S., 2016
List of Figures
Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2016
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016
Figure 1 9: Neurological Device Markets Covered, U.S., 2016
Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2)
Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2)
Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2)
Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2)
Figure 1 14: Key Report Updates
Figure 1 15: Version History
Figure 2 1: Neurology Disease Overview
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016
Figure 3 1: Total Neurological Device Market, U.S., 2013 – 2023 (US$M)
Figure 3 2: Neurological Device Market by Segment, U.S., 2013 – 2023 (US$M) (1 of 3)
Figure 3 3: Neurological Device Market by Segment, U.S., 2013 – 2023 (US$M) (2 of 3)
Figure 3 4: Neurological Device Market by Segment, U.S., 2013 – 2023 (US$M) (3 of 3)
Figure 3 5: Neurological Device Market Growth by Segment, U.S., 2013 – 2023 (1 of 3)
Figure 3 6: Neurological Device Market Growth by Segment, U.S., 2013 – 2023 (2 of 3)
Figure 3 7: Neurological Device Market Growth by Segment, U.S., 2013 – 2023 (3 of 3)
Figure 3 8: Drivers and Limiters, Neurological Device Market, U.S., 2016
Figure 3 9: Leading Competitors, Neurological Device Market, U.S., 2016 (1 of 3)
Figure 3 10: Leading Competitors, Neurological Device Market, U.S., 2016 (2 of 3)
Figure 3 11: Leading Competitors, Neurological Device Market, U.S., 2016 (3 of 3)
Figure 5 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report